SPECIFICATION OF FUNCTIONAL CRANIAL PLACODE DERIVATIVES FROM HUMAN PLURIPOTENT STEM CELLS
    2.
    发明申请
    SPECIFICATION OF FUNCTIONAL CRANIAL PLACODE DERIVATIVES FROM HUMAN PLURIPOTENT STEM CELLS 审中-公开
    来自人类肺癌干细胞的功能性起始位点衍生物的规范

    公开(公告)号:US20160326491A1

    公开(公告)日:2016-11-10

    申请号:US15159351

    申请日:2016-05-19

    IPC分类号: C12N5/0793 A61K35/12

    摘要: Cranial placodes are embryonic structures essential for sensory and endocrine organ development. The efficient derivation of cranial placodes from human pluripotent stem cells is disclosed where the timed removal of the BMP inhibitor Noggin, a component of the dual-SMAD inhibition strategy of neural induction, triggers placode induction at the expense of CNS fates. Further fate specification at the pre-placode stage enables the selective generation of placode-derived trigeminal ganglia capable of in vivo engraftment, mature lens fibers and anterior pituitary hormone-producing cells that upon transplantation produce hormones including, but not limited to, human growth hormone and adrenocortiocotropic hormone in vivo. Alternatively, anterior pituitary hormone-producing cells are generated in cell culture systems in vitro.

    摘要翻译: 颅内扩张是感觉和内分泌器官发育所必需的胚胎结构。 公开了来自人多能干细胞的头颅细胞的有效衍生,其中定时去除BMP抑制剂Noggin,神经诱导的双SMAD抑制策略的一个组成部分以CNS命运为代价触发细胞诱导。 在预分段阶段的进一步的命运规范使得能够选择性地产生能够体内植入的衍生的三叉神经节,成熟透镜纤维和垂体前叶激素产生细胞,其在移植时产生激素,包括但不限于人生长激素 和肾上腺皮质激素在体内。 或者,在体外在细胞培养系统中产生垂体前激素产生细胞。

    Visual function disorder improving agents
    5.
    发明申请
    Visual function disorder improving agents 失效
    视觉功能障碍改善剂

    公开(公告)号:US20040106646A1

    公开(公告)日:2004-06-03

    申请号:US10474369

    申请日:2003-11-18

    摘要: The present invention provides a visual function disorder improving agent containing a compound having Rho kinase inhibitory activity, particularly (R)-(null)-N-(1H-pyrrolonull2,3-bnullpyridin-4-yl)-4-(1-aminoethyl)benzamide, as an effective component. This agent has axon of the retinal ganglion cellal extension promoting action and optic nerve cell regeneration promoting action, and is useful for the treatment of a visual function disorder associated with various eye diseases caused by damage, defects, degeneration and the like in the retinal or optic nerve.

    摘要翻译: 本发明提供含有具有Rho激酶抑制活性的化合物的视觉功能紊乱改善剂,特别是(R) - (+) - N-(1H-吡咯并[2,3-b]吡啶-4-基)-4- (1-氨基乙基)苯甲酰胺作为有效成分。 该药剂具有视网膜神经节细胞延伸促进作用和视神经细胞再生促进作用的轴突,并且可用于治疗由视网膜中的损伤,缺陷,变性等引起的各种眼病的视觉功能障碍, 视神经

    "> Protecting Groups For
    7.
    发明申请
    Protecting Groups For "Z Nucleotide" And Methods Thereof 有权
    “Z核苷酸”的保护基及其方法

    公开(公告)号:US20150353594A1

    公开(公告)日:2015-12-10

    申请号:US14724613

    申请日:2015-05-28

    IPC分类号: C07H23/00 C07H7/06

    摘要: The present disclosure provides a unique methodology and protecting groups that enable synthesis of oligonucleotides having Z nucleotide in an easy, clean and site-specific fashion with high yield. In particular, the method causes little to no damage to oligonucleotide product and does not modify the Z nucleotide itself. The invention provides a viable protection strategy for efficient synthesis of long oligonucleotides with Z nucleotide incorporated therein.

    摘要翻译: 本公开提供了一种独特的方法和保护基团,其能够以高产率以易于,清洁和位点特异性方式合成具有Z核苷酸的寡核苷酸。 特别地,该方法对寡核苷酸产物几乎不产生损伤,并且不改变Z核苷酸本身。 本发明提供了用于有效合成具有Z核苷酸的长寡核苷酸的可行保护策略。

    Azo coupling reactions of hydrophobic compounds
    8.
    发明申请
    Azo coupling reactions of hydrophobic compounds 失效
    疏水化合物的偶氮偶联反应

    公开(公告)号:US20060235227A1

    公开(公告)日:2006-10-19

    申请号:US11109388

    申请日:2005-04-19

    申请人: Catherine Mineur

    发明人: Catherine Mineur

    IPC分类号: C07D211/00

    CPC分类号: C07D211/00

    摘要: A process for forming a diazo compound comprises reacting an organic compound bearing an acidic hydrogen with an aryl-diazonium salt in the presence of an inorganic base and a non-halogenated solvent. The process is simpler and more environmentally friendly than known processes.

    摘要翻译: 形成重氮化合物的方法包括在无机碱和非卤化溶剂的存在下使带有酸性氢的有机化合物与芳基重氮盐反应。 该过程比已知方法更简单和更环保。